IRVINE, Calif., Sept. 8 Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced that the Fire Department of New York ...

Medical device creator Masimo announced today its latest 510(k) clearance from the U.S. Food and Drug Administration for the Rad-G pulse oximeter. The Rad-G is a handheld device that combines Masimo’s ...

Masimo Corporation MASI recently announced that the Rad-G with Temperature has received the CE marking. The device is a handheld one offering clinically proven Signal Extraction Technology (SET) pulse ...

Masimo announced FDA clearance and full market release of Rad-97™ Pulse CO-Oximeter®, including configurations with blood pressure and capnography.

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...

Masimo Corporation MASI recently announced the findings of a study published in Clinical Medicine Insights: Pediatrics, demonstrating the experience using the Masimo Rad-G Pulse Oximeter. The study ...

Masimo Corporation MASI received FDA approval for the domestic use of Rad-97 Pulse CO-Oximeter. This product will offer non-invasive and continuous monitoring. The product comprises Measure-through ...

Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97 ™ Pulse CO-Oximeter ®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ SET ® pulse oximetry and upgradeable rainbow ...

Masimo Corporation MASI recently received FDA clearance of the Rad-G Pulse Oximeter — a rugged handheld device — offering clinically proven Signal Extraction Technology (SET) pulse oximetry, ...

Masimo Founder and CEO, Joe Kiani, stated, "This statewide initiative to equip every fire district with our Rad-57s arms Delaware first responders with the technology they need to protect themselves ...